表紙
市場調査レポート

VG Life Sciences, Inc.:製品パイプライン分析

VG Life Sciences, Inc. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 307843
出版日 ページ情報 英文 27 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
VG Life Sciences, Inc.:製品パイプライン分析 VG Life Sciences, Inc. - Product Pipeline Review - 2015
出版日: 2015年08月26日 ページ情報: 英文 27 Pages
概要

VG Life Sciences, Inc.は、癌、感染症、炎症性疾患向けの治療薬を発見、開発する医薬品開発企業です。

当レポートでは、VG Life Sciences, Inc.の医薬品開発パイプラインの現況と各開発段階の比較分析と薬剤プロファイル、標的、投与経路、分子タイプ、作用機序別の薬剤評価、休止中の開発プロジェクトなどの情報を提供しています。

VG Life Sciences, Inc.の基本情報

  • 概要
  • 主要情報
  • 企業情報

VG Life Sciences, Inc.:R&Dの概要

  • 主な治療範囲

VG Life Sciences, Inc.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • 併用療法モダリティ

VG Life Sciences, Inc.:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

VG Life Sciences, Inc.:薬剤プロファイル

  • hydroxychloroquine + sorafenib tosylate
  • VG-1177
  • 炎症性腸疾患向けのペプチド

VG Life Sciences, Inc.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

VG Life Sciences, Inc.:最近のパイプライン動向

VG Life Sciences, Inc.:休止中のプロジェクト

VG Life Sciences, Inc.:本社と子会社の所在地

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07462CDB

Summary

Global Markets Direct's, 'VG Life Sciences, Inc. - Product Pipeline Review - 2015', provides an overview of the VG Life Sciences, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of VG Life Sciences, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of VG Life Sciences, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of VG Life Sciences, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the VG Life Sciences, Inc.'s pipeline products

Reasons to buy

  • Evaluate VG Life Sciences, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of VG Life Sciences, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the VG Life Sciences, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of VG Life Sciences, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of VG Life Sciences, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of VG Life Sciences, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • VG Life Sciences, Inc. Snapshot
    • VG Life Sciences, Inc. Overview
    • Key Information
    • Key Facts
  • VG Life Sciences, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • VG Life Sciences, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • VG Life Sciences, Inc. - Pipeline Products Glance
    • VG Life Sciences, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • VG Life Sciences, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • VG Life Sciences, Inc. - Drug Profiles
    • hydroxychloroquine + sorafenib tosylate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VG-1177
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Peptide for Inflammatory Bowel Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • VG Life Sciences, Inc. - Pipeline Analysis
    • VG Life Sciences, Inc. - Pipeline Products by Target
    • VG Life Sciences, Inc. - Pipeline Products by Route of Administration
    • VG Life Sciences, Inc. - Pipeline Products by Molecule Type
    • VG Life Sciences, Inc. - Pipeline Products by Mechanism of Action
  • VG Life Sciences, Inc. - Recent Pipeline Updates
  • VG Life Sciences, Inc. - Dormant Projects
  • VG Life Sciences, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • VG Life Sciences, Inc., Key Information
  • VG Life Sciences, Inc., Key Facts
  • VG Life Sciences, Inc. - Pipeline by Indication, 2015
  • VG Life Sciences, Inc. - Pipeline by Stage of Development, 2015
  • VG Life Sciences, Inc. - Monotherapy Products in Pipeline, 2015
  • VG Life Sciences, Inc. - Combination Treatment Modalities in Pipeline, 2015
  • VG Life Sciences, Inc. - Phase I, 2015
  • VG Life Sciences, Inc. - Preclinical, 2015
  • VG Life Sciences, Inc. - Discovery, 2015
  • VG Life Sciences, Inc. - Pipeline by Target, 2015
  • VG Life Sciences, Inc. - Pipeline by Route of Administration, 2015
  • VG Life Sciences, Inc. - Pipeline by Molecule Type, 2015
  • VG Life Sciences, Inc. - Pipeline Products by Mechanism of Action, 2015
  • VG Life Sciences, Inc. - Recent Pipeline Updates, 2015
  • VG Life Sciences, Inc. - Dormant Developmental Projects,2015

List of Figures

  • VG Life Sciences, Inc. - Pipeline by Top 10 Indication, 2015
  • VG Life Sciences, Inc. - Pipeline by Stage of Development, 2015
  • VG Life Sciences, Inc. - Monotherapy Products in Pipeline, 2015
  • VG Life Sciences, Inc. - Pipeline by Top 10 Target, 2015
  • VG Life Sciences, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • VG Life Sciences, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • VG Life Sciences, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top